When researchers prepare each year’s flu vaccine, it is designed to protect against specific strains they expect to be widely circulated. The vaccine will produce specific antibodies to those strains if a person becomes infected with them. So long at the right antibodies in the vaccine are present to combat the strain a person is exposed to, they should be protected from the flu that season.
Here are three things to know about the viral mutations.
1. The researchers identified 10 different viral mutations that circulated in the 2014 to 2015 season. These mutations made the circulating flu strains differ from the strains the vaccines were prepared to inoculate against.
2. The World Health Organization has recommended that the seasonal flu vaccine be appropriately updated for the upcoming 2015 to 2016 season to account for the mutations.
3. Research is currently underway to determine whether antibodies from the new vaccine strain will have the desired effect on the strains of influenza that will likely circulate next season.
More articles on infection control:
Plague kills teen in Colorado: 5 things to know
Endoscopes and MDROs: How to avoid an outbreak
CMS data collection rules may detract from infection control
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
